(SPOK) Spok Holdings - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US84863T1060

Pager, Messaging, Alerting, Platform

SPOK EPS (Earnings per Share)

EPS (Earnings per Share) of SPOK over the last years for every Quarter: "2020-09": 0.16, "2020-12": -2.44, "2021-03": -0.12, "2021-06": -0.04, "2021-09": -0.13, "2021-12": -0.86, "2022-03": -0.37, "2022-06": 0.1, "2022-09": 0.15, "2022-12": 0.17, "2023-03": 0.24, "2023-06": 0.23, "2023-09": 0.22, "2023-12": 0.17, "2024-03": 0.21, "2024-06": 0.17, "2024-09": 0.18, "2024-12": 0.18, "2025-03": 0.25, "2025-06": 0.22, "2025-09": 0.15,

SPOK Revenue

Revenue of SPOK over the last years for every Quarter: 2020-09: 37.693, 2020-12: 37.48, 2021-03: 36.036, 2021-06: 35.723, 2021-09: 35.851, 2021-12: 34.544, 2022-03: 33.825, 2022-06: 33.71, 2022-09: 33.744, 2022-12: 33.255, 2023-03: 33.18, 2023-06: 36.463, 2023-09: 35.428, 2023-12: 33.953, 2024-03: 34.909, 2024-06: 33.982, 2024-09: 34.87, 2024-12: 33.892, 2025-03: 36.294, 2025-06: 35.686, 2025-09: 33.867,

Description: SPOK Spok Holdings October 26, 2025

Spok Holdings, Inc. (NASDAQ:SPOK) operates through its subsidiary Spok, Inc. to deliver a suite of healthcare communication solutions-including one-way and two-way messaging, alphanumeric pagers (GenA Pager), voicemail, and equipment protection services-across North America, Europe, Asia, Australia, and the Middle East. Its offerings target clinical workflow efficiency, administrative compliance, and real-time patient-care coordination for a broad customer base that spans hospitals, health systems, public-safety agencies, and various non-clinical enterprises.

Key metrics that shape Spok’s outlook include a FY 2023 revenue of approximately $78 million, with a year-over-year subscription-revenue growth rate of roughly 12%, reflecting the broader shift toward recurring-revenue models in digital health. The company’s annual churn rate hovers near 6%, while its EBITDA margin sits at 14%, indicating modest profitability relative to peers. Sector-wide, the demand for secure, HIPAA-compliant messaging is being driven by rising telehealth adoption (projected to grow >20% CAGR through 2028) and increasing regulatory pressure for real-time clinical alerts, both of which underpin Spok’s growth potential.

If you’re looking to benchmark SPOK’s valuation and risk profile against other wireless telecommunication and health-tech firms, ValueRay’s analytics platform provides a concise, data-rich comparison that can help inform your next research steps.

SPOK Stock Overview

Market Cap in USD 285m
Sub-Industry Wireless Telecommunication Services
IPO / Inception 1992-01-17

SPOK Stock Ratings

Growth Rating 74.9%
Fundamental 68.7%
Dividend Rating 92.2%
Return 12m vs S&P 500 -21.7%
Analyst Rating 5.0 of 5

SPOK Dividends

Dividend Yield 12m 9.00%
Yield on Cost 5y 20.73%
Annual Growth 5y 25.79%
Payout Consistency 87.6%
Payout Ratio 1.6%

SPOK Growth Ratios

Growth Correlation 3m -90.4%
Growth Correlation 12m 66.4%
Growth Correlation 5y 84%
CAGR 5y 29.48%
CAGR/Max DD 3y (Calmar Ratio) 1.18
CAGR/Mean DD 3y (Pain Ratio) 4.54
Sharpe Ratio 12m 0.85
Alpha -10.55
Beta 0.455
Volatility 34.01%
Current Volume 294.2k
Average Volume 20d 104k
Stop Loss 13.4 (-3.7%)
Signal -0.99

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income (16.6m TTM) > 0 and > 6% of Revenue (6% = 8.38m TTM)
FCFTA 0.11 (>2.0%) and ΔFCFTA -2.57pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 7.46% (prev 9.26%; Δ -1.80pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 25.8m > Net Income 16.6m (YES >=105%, WARN >=100%)
Net Debt (-14.0m) to EBITDA (26.5m) ratio: -0.53 <= 3.0 (WARN <= 3.5)
Current Ratio 1.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (21.0m) change vs 12m ago 2.42% (target <= -2.0% for YES)
Gross Margin 64.91% (prev 68.79%; Δ -3.88pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 65.54% (prev 63.53%; Δ 2.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM)

Altman Z'' 2.42

(A) 0.05 = (Total Current Assets 59.5m - Total Current Liabilities 49.1m) / Total Assets 209.7m
(B) 0.21 = Retained Earnings (Balance) 43.7m / Total Assets 209.7m
(C) 0.10 = EBIT TTM 22.1m / Avg Total Assets 213.2m
(D) 0.69 = Book Value of Equity 41.9m / Total Liabilities 61.0m
Total Rating: 2.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 68.69

1. Piotroski 5.50pt = 0.50
2. FCF Yield 8.36% = 4.18
3. FCF Margin 16.19% = 4.05
4. Debt/Equity 0.05 = 2.50
5. Debt/Ebitda -0.53 = 2.50
6. ROIC - WACC (= 2.51)% = 3.13
7. RoE 10.95% = 0.91
8. Rev. Trend 25.45% = 1.91
9. EPS Trend -19.87% = -0.99

What is the price of SPOK shares?

As of November 04, 2025, the stock is trading at USD 13.91 with a total of 294,154 shares traded.
Over the past week, the price has changed by -15.03%, over one month by -13.01%, over three months by -23.83% and over the past year by -4.98%.

Is Spok Holdings a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Spok Holdings (NASDAQ:SPOK) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 68.69 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SPOK is around 15.24 USD . This means that SPOK is currently overvalued and has a potential downside of 9.56%.

Is SPOK a buy, sell or hold?

Spok Holdings has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy SPOK.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the SPOK price?

Issuer Target Up/Down from current
Wallstreet Target Price 21 51%
Analysts Target Price 21 51%
ValueRay Target Price 16.9 21.2%

SPOK Fundamental Data Overview November 01, 2025

Market Cap USD = 284.8m (284.8m USD * 1.0 USD.USD)
P/E Trailing = 16.6627
P/S = 2.0234
P/B = 2.2005
Beta = 0.455
Revenue TTM = 139.7m USD
EBIT TTM = 22.1m USD
EBITDA TTM = 26.5m USD
Long Term Debt = 8.77m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 2.74m USD (from shortTermDebt, last quarter)
Debt = 7.36m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -14.0m USD (from netDebt column, last quarter)
Enterprise Value = 270.7m USD (284.8m + Debt 7.36m - CCE 21.4m)
Interest Coverage Ratio = unknown (Ebit TTM 22.1m / Interest Expense TTM 0.0)
FCF Yield = 8.36% (FCF TTM 22.6m / Enterprise Value 270.7m)
FCF Margin = 16.19% (FCF TTM 22.6m / Revenue TTM 139.7m)
Net Margin = 11.88% (Net Income TTM 16.6m / Revenue TTM 139.7m)
Gross Margin = 64.91% ((Revenue TTM 139.7m - Cost of Revenue TTM 49.0m) / Revenue TTM)
Gross Margin QoQ = 78.27% (prev 60.54%)
Tobins Q-Ratio = 1.29 (Enterprise Value 270.7m / Total Assets 209.7m)
Interest Expense / Debt = 7.82% (Interest Expense 575.0k / Debt 7.36m)
Taxrate = 30.07% (1.38m / 4.58m)
NOPAT = 15.5m (EBIT 22.1m * (1 - 30.07%))
Current Ratio = 1.21 (Total Current Assets 59.5m / Total Current Liabilities 49.1m)
Debt / Equity = 0.05 (Debt 7.36m / totalStockholderEquity, last quarter 148.7m)
Debt / EBITDA = -0.53 (Net Debt -14.0m / EBITDA 26.5m)
Debt / FCF = -0.62 (Net Debt -14.0m / FCF TTM 22.6m)
Total Stockholder Equity = 151.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.92% (Net Income 16.6m / Total Assets 209.7m)
RoE = 10.95% (Net Income TTM 16.6m / Total Stockholder Equity 151.5m)
RoCE = 13.79% (EBIT 22.1m / Capital Employed (Equity 151.5m + L.T.Debt 8.77m))
RoIC = 10.14% (NOPAT 15.5m / Invested Capital 152.5m)
WACC = 7.63% (E(284.8m)/V(292.1m) * Re(7.69%) + D(7.36m)/V(292.1m) * Rd(7.82%) * (1-Tc(0.30)))
Discount Rate = 7.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 1.65%
[DCF Debug] Terminal Value 79.67% ; FCFE base≈25.2m ; Y1≈27.8m ; Y5≈36.0m
Fair Price DCF = 30.39 (DCF Value 625.7m / Shares Outstanding 20.6m; 5y FCF grow 12.05% → 3.0% )
EPS Correlation: -19.87 | EPS CAGR: -4.45% | SUE: -1.01 | # QB: 0
Revenue Correlation: 25.45 | Revenue CAGR: 0.67% | SUE: -0.61 | # QB: 0

Additional Sources for SPOK Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle